JP2012031175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012031175A5 JP2012031175A5 JP2011179702A JP2011179702A JP2012031175A5 JP 2012031175 A5 JP2012031175 A5 JP 2012031175A5 JP 2011179702 A JP2011179702 A JP 2011179702A JP 2011179702 A JP2011179702 A JP 2011179702A JP 2012031175 A5 JP2012031175 A5 JP 2012031175A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- content
- less
- polyunsaturated fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 16
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 8
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 4
- 235000021342 arachidonic acid Nutrition 0.000 claims 4
- 229940114079 arachidonic acid Drugs 0.000 claims 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 4
- 229920002670 Fructan Polymers 0.000 claims 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 3
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 claims 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 2
- 229920001202 Inulin Polymers 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 2
- 229940029339 inulin Drugs 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 108010011756 Milk Proteins Proteins 0.000 claims 1
- 102000014171 Milk Proteins Human genes 0.000 claims 1
- 102000000591 Tight Junction Proteins Human genes 0.000 claims 1
- 108010002321 Tight Junction Proteins Proteins 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 210000005027 intestinal barrier Anatomy 0.000 claims 1
- 230000007358 intestinal barrier function Effects 0.000 claims 1
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 claims 1
- 235000010598 long-chain omega-6 fatty acid Nutrition 0.000 claims 1
- 235000021239 milk protein Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000035699 permeability Effects 0.000 claims 1
- 238000006116 polymerization reaction Methods 0.000 claims 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 210000001578 tight junction Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011179702A JP5502817B2 (ja) | 2011-08-19 | 2011-08-19 | 障壁の完全性の改善 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011179702A JP5502817B2 (ja) | 2011-08-19 | 2011-08-19 | 障壁の完全性の改善 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007517980A Division JP4903695B2 (ja) | 2004-06-22 | 2004-06-22 | 障壁の完全性の改善 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012031175A JP2012031175A (ja) | 2012-02-16 |
| JP2012031175A5 true JP2012031175A5 (enExample) | 2013-05-30 |
| JP5502817B2 JP5502817B2 (ja) | 2014-05-28 |
Family
ID=45845014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011179702A Expired - Lifetime JP5502817B2 (ja) | 2011-08-19 | 2011-08-19 | 障壁の完全性の改善 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5502817B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1758469T5 (pl) * | 2004-06-22 | 2014-01-31 | Nutricia Nv | Poprawa integralności bariery u pacjentów z HIV przez zastosowanie kwasów tłuszczowych |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3419897B2 (ja) * | 1994-07-22 | 2003-06-23 | 明治乳業株式会社 | 低アレルギー性調製乳 |
| DE19836339B4 (de) * | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
| NL1018832C2 (nl) * | 2001-08-27 | 2003-03-03 | Friesland Brands Bv | Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel. |
-
2011
- 2011-08-19 JP JP2011179702A patent/JP5502817B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2570205A1 (en) | Improvement of intestinal barrier integrity | |
| US8241659B2 (en) | Nutrition with lipids and non-digestible saccharides | |
| CA2648826C (en) | Preterm formula | |
| CN104955344A (zh) | 包含神经保护膳食寡糖的营养组合物 | |
| JP2008519796A5 (enExample) | ||
| JP2018537441A5 (enExample) | ||
| ES2538037T3 (es) | Emulsiones nutricionales de viscosidad inducida | |
| AU2015327029B2 (en) | Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses. | |
| JP2012509292A5 (enExample) | ||
| AU2019280019A1 (en) | Nutritional composition for use in promoting gut and/or liver maturation and/or repair | |
| CN104853619A (zh) | 具有脂质小球的婴儿营养物增加以后生命中的能量消耗和代谢灵活性 | |
| JP2012031175A5 (enExample) | ||
| CN107072277A (zh) | 用于改善行为的脂质组合物 | |
| RU2586150C2 (ru) | Добавка для матери, предназначенная для укрепления иммунной системы ребенка | |
| ES2704957T3 (es) | Método para reducir la aparición de infecciones en niños pequeños | |
| US9918952B2 (en) | Powderous formulation | |
| WO2012044155A1 (en) | Fat composition for programming immune response |